Skip to content

Bright Light Therapy for Irregular sleep-wake cycles and cognitive impairment in patients with Schizophrenia

Bright Light Therapy for Irregular sleep-wake cycles and cognitive impairment in patients with Schizophrenia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039740
Enrollment
Unknown
Registered
2020-11-07
Start date
2020-08-04
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Schizophrenia-Bright light:Bright light
Schizophrenia:Dim light
Healthy control:withour intervention

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) The diagnosis meets the diagnostic criteria of DSM-IV axis I regarding schizophrenia; 2) The age of the patient is 18-65 years old; 3) Primary school and above; 4) PSQI score > 7; 5) Stably take antipsychotics for at least 2 weeks at the beginning of the study.

Exclusion criteria

Exclusion criteria: 1) Except for schizophrenia, those who meet the diagnostic criteria of any DSM-IV axis I mental illness; 2) In the past 6 months, patients who meet the DSM-IV substance abuse or dependence criteria; 3) Patients with cognitive impairment (including mental retardation) or personality disorder (severe enough to affect participation in the study) are undergoing any other clinical trials; 4) Those who are undergoing any other clinical trials; 5) Severe physical disease, such as heart disease (that is, heart function of grade II and above) or basic heart rate 140mmHg; diastolic blood pressure 90mmHg; liver , Kidney function is obviously abnormal; 6) Those suffering from diseases of the visual pathway of the eye (cataracts, glaucoma, high myopia, retinal detachment, optic nerve atrophy, macular degeneration); 7) Suffering from endocrine diseases such as diabetes, thyroid disease, pituitary tumor, etc.

Design outcomes

Primary

MeasureTime frame
PANSS;ESS;Pittsburgh Sleep Quality Index;The insomnia severity index;Morningness-eveningness questionnaire;First night effect of sleep;

Countries

China

Contacts

Public ContactHongqiang Sun

Peking University Sixth Hospital

sunhq@bjmu.edu.cn+86 13911043951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026